1 – 16 of 16
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
PARKIN is not required to sustain OXPHOS function in adult mammalian tissues
(
- Contribution to journal › Article
-
Mark
Predictors of short-term anxiety outcome in subthalamic stimulation for Parkinson’s disease
(
- Contribution to journal › Article
- 2023
-
Mark
Regulators of proteostasis are translationally repressed in fibroblasts from patients with sporadic and LRRK2-G2019S Parkinson’s disease
(
- Contribution to journal › Article
-
Mark
The IPDGC/GP2 Hackathon - an open science event for training in data science, genomics, and collaboration using Parkinson’s disease data
(
- Contribution to journal › Article
-
Mark
Time to workforce exit after a Parkinson's disease diagnosis
(
- Contribution to journal › Article
- 2022
-
Mark
Safinamide in the treatment pathway of Parkinson’s Disease : a European Delphi Consensus
(
- Contribution to journal › Article
-
Mark
Comparison of risk factors for Parkinson's disease, coronary events and ischemic stroke
(
- Contribution to journal › Article
-
Mark
Validation of the PD home diary for assessment of motor fluctuations in advanced Parkinson's disease
(
- Contribution to journal › Article
- 2021
-
Mark
Clinical classification systems and long-term outcome in mid- and late-stage Parkinson’s disease
(
- Contribution to journal › Article
- 2018
-
Mark
Reduced workforce participation 5 years prior to first Parkinson’s disease sick-leave
(
- Contribution to journal › Article
-
Mark
Systematic evaluation of levodopa-carbidopa intestinal gel patient-responder characteristics
(
- Contribution to journal › Article
-
Mark
Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson's disease
(
- Contribution to journal › Scientific review
- 2017
-
Mark
GFORCE-PD still going strong in 2016
(
- Contribution to journal › Scientific review
-
Mark
Distribution and impact on quality of life of the pain modalities assessed by the King's Parkinson's disease pain scale
(
- Contribution to journal › Article
- 2016
-
Mark
Effect of levodopa-carbidopa intestinal gel on resting tremors in patients with advanced Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Non-oral dopaminergic therapies for Parkinson's disease : current treatments and the future
(
- Contribution to journal › Scientific review